SS-31 Peptide FDA Approved? The Honest Answer

No. SS-31 (elamipretide) is not FDA approved for human use in the United States. It has been tested in clinical trials for rare mitochondrial diseases and for dry age-related macular degeneration, but the FDA has never granted marketing approval for any SS-31 product. If you are searching for is ss 31 fda approved, the honest answer is no, and any seller implying otherwise is misrepresenting what it is selling.

What Is SS-31?

The ss 31 peptide is a short synthetic molecule made of four amino acids. It was designed to concentrate inside mitochondria and bind to cardiolipin, a lipid on the inner mitochondrial membrane that supports cellular energy production.

To understand what does ss 31 peptide do, think of it as an attempt to stabilize mitochondrial energy machinery when that machinery is damaged. It is not a vitamin, a hormone, or an approved drug. It is an experimental compound.

• Developer: Stealth BioTherapeutics, which calls the molecule elamipretide.
• Class: mitochondria-targeted tetrapeptide, given by subcutaneous injection in human trials.
• Legal status: sold as a research chemical, labeled "for research use only, not for human consumption."

SS-31 FDA Approval Status at a Glance

The FDA has shown genuine interest in elamipretide for rare disease, but designations are not approvals. A designation can speed up review, provide tax incentives, or extend market exclusivity, but it does not make a drug legal to prescribe.

Regulatory action	What it means	Human use approved?
Orphan drug designation for Barth syndrome	Development incentives for a rare-disease drug	No
Rare pediatric disease designation	Eligibility for a priority review voucher if approved	No
FDA advisory committee review (October 2024)	Independent panel voted against recommending approval for Barth syndrome	No
New Drug Application / marketing approval	The step required before a prescription drug can be sold	Not granted

No SS-31 or elamipretide product currently holds FDA approval for any human condition. That status applies to injectable and topical versions alike.

What Has SS-31 Been Studied For?

Most human data on elamipretide comes from small trials in rare mitochondrial conditions and eye disease. Results have been mixed, and no program has produced evidence strong enough for approval.

Condition studied	Trial stage	Reported outcome
Barth syndrome	Phase 2/3 (TAZPOWER)	Some functional signals; FDA panel voted against approval in 2024
Primary mitochondrial myopathy	Phase 3 (MMPOWER-3)	Did not meet its primary endpoint
Dry age-related macular degeneration	Phase 2 (ReCLAIM-2)	Missed its primary endpoint after early positive signals

Other mitochondrial and cardiac conditions have been explored in earlier-stage research. None of that work has changed the regulatory picture.

SS-31 Peptide Benefits and Side Effects: What Research Shows

Reports of ss-31 peptide benefits and side effects come mostly from small trials and open-label extensions, not from large placebo-controlled studies that hit their goals. That distinction matters when you read confident claims online.

In published trial reports, the most commonly noted side effects were generally mild and included:

• Injection-site reactions such as pain, redness, or swelling
• Headache
• Nausea
• Fatigue

Some participants showed improvements in walking distance, muscle strength, or vision-related measures, but those changes were not consistent enough to satisfy regulators.

SS-31 has not been proven to treat, cure, or prevent any disease in humans.

SS-31 Peptide Dosing: What Trials Have Used

There is no FDA-approved ss-31 peptide dosing schedule, because the drug is not approved. Any numbers circulating online come from research protocols, not from prescribing instructions.

In Stealth's clinical programs, the most frequently used regimen was 40 mg given as a once-daily subcutaneous injection. That same ss 31 peptide dosage appeared across Barth syndrome, mitochondrial myopathy, and dry macular degeneration studies.

Doses used in research are not recommendations for self-administration. A research protocol includes monitoring, lab work, and medical oversight that a home injection routine does not.

Why Buying SS-31 Online Is Risky

Suppliers offering ss 31 peptide for sale online typically sell a lyophilized powder with a research-use-only label. That label is a legal disclaimer, not a quality guarantee.

If you buy ss-31 peptide from a research chemical vendor, you are accepting several unknowns at once:

1. Identity and purity: the FDA does not review these products, and independent testing often finds underdosed or mislabeled vials.
2. Sterility: powders intended for lab benches are not manufactured to injectable standards.
3. Dosing errors: without a validated concentration, measuring a dose accurately is guesswork.
4. No safety net: there is no adverse event reporting, no recall system, and no pharmacist to check interactions.

Buying a research chemical for personal injection is not the same as obtaining a prescription drug, and the FDA has warned consumers about unapproved peptide products sold online.

The Bottom Line

SS-31 is a scientifically interesting molecule with real clinical research behind it, and it is still not an approved medicine. The gap between "being studied" and "FDA approved" is exactly where most online marketing lives.

If you have a mitochondrial condition or another serious diagnosis, the safer path is to ask your healthcare professional about enrolling in a registered clinical trial rather than sourcing peptides from a website. A qualified clinician can review your options, monitor you properly, and flag interactions that a vendor never will.

COMMON QUESTIONS

Frequently Asked Questions

Is SS-31 FDA approved?

No. SS-31, also called elamipretide, has not received FDA approval for any human use in the United States. The FDA has granted orphan drug and rare pediatric disease designations, but in October 2024 an FDA advisory committee voted against recommending approval for Barth syndrome. Designations speed up review and offer incentives; they are not approvals.

Can you legally buy SS-31 peptide online?

Sellers can market SS-31 as a research chemical labeled "not for human consumption." Selling it for human use without FDA approval is not permitted, and buying it to inject yourself means using an unapproved, unreviewed product. Purity, sterility, and actual peptide content are not verified by any regulator.

What has SS-31 been studied for in humans?

Elamipretide has been tested in trials for Barth syndrome, primary mitochondrial myopathy, and dry age-related macular degeneration. The Phase 3 mitochondrial myopathy trial and the Phase 2 dry AMD trial did not meet their primary endpoints, and the Barth syndrome program failed to win advisory committee support. Research continues, but no trial has produced evidence sufficient for approval.